MyoKardia Inc. [NASDAQ: MYOK] jumped around 80.74 points on Monday, while shares priced at $220.34 at the close of the session, up 57.84%.
MyoKardia Inc. stock is now 202.31% up from its year-to-date (YTD) trading value. MYOK Stock saw the intraday high of $224.00 and lowest of $219.72 per share. The company’s 52-week high price is 140.93, which means current price is +416.62% above from all time high which was touched on 10/05/20.
Compared to the average trading volume of 384.49K shares, MYOK reached a trading volume of 16882247 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about MyoKardia Inc. [MYOK]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MYOK shares is $137.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MYOK stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for MyoKardia Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 20, 2019. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on October 01, 2018, representing the official price target for MyoKardia Inc. stock. Previously, the target price had yet another raise to $90, while Citigroup analysts kept a Buy rating on MYOK stock.
The Average True Range (ATR) for MyoKardia Inc. is set at 11.07 The Price to Book ratio for the last quarter was 12.09, with the Price to Cash per share for the same quarter was set at 17.26.
How has MYOK stock performed recently?
MyoKardia Inc. [MYOK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 64.56. With this latest performance, MYOK shares gained by 94.03% in over the last four-week period, additionally plugging by 358.56% over the last 6 months – not to mention a rise of 306.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MYOK stock in for the last two-week period is set at 90.69, with the RSI for the last a single of trading hit 94.05, and the three-weeks RSI is set at 87.46 for MyoKardia Inc. [MYOK]. The present Moving Average for the last 50 days of trading for this stock 114.44, while it was recorded at 154.10 for the last single week of trading, and 85.56 for the last 200 days.
MyoKardia Inc. [MYOK]: Deeper insight into the fundamentals
Return on Total Capital for MYOK is now -53.48, given the latest momentum, and Return on Invested Capital for the company is -71.11. Return on Equity for this stock declined to -71.11, with Return on Assets sitting at -63.99. When it comes to the capital structure of this company, MyoKardia Inc. [MYOK] has a Total Debt to Total Equity ratio set at 0.09. Additionally, MYOK Total Debt to Total Capital is recorded at 0.09, with Total Debt to Total Assets ending up at 0.08.
Reflecting on the efficiency of the workforce at the company, MyoKardia Inc. [MYOK] managed to generate an average of -$1,175,374 per employee.MyoKardia Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 21.00 and a Current Ratio set at 21.00.
Earnings analysis for MyoKardia Inc. [MYOK]
With the latest financial reports released by the company, MyoKardia Inc. posted -3.07/share EPS, while the average EPS was predicted by analysts to be reported at -1.91/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -60.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MYOK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MyoKardia Inc. go to 50.90%.
Insider trade positions for MyoKardia Inc. [MYOK]
There are presently around $12,132 million, in the hands of institutional investors. The top three institutional holders of MYOK stocks are: FMR LLC with ownership of 7,919,327, which is approximately 13.357% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 4,564,674 shares of the stock with an approximate value of $1.01 billion in MYOK stocks shares; and BLACKROCK INC., currently with $987.08 million in MYOK stock with ownership of nearly 8.478% of the company’s market capitalization.
Positions in MyoKardia Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 168 institutional holders increased their position in MyoKardia Inc. [NASDAQ:MYOK] by around 10,996,004 shares. Additionally, 77 investors decreased positions by around 4,589,682 shares, while 18 investors held positions by with 39,476,381 shares. The mentioned changes placed institutional holdings at 55,062,067 shares, according to the latest SEC report filing. MYOK stock had 69 new institutional investments in for a total of 2,103,820 shares, while 27 institutional investors sold positions of 1,524,406 shares during the same period.